The INJ Supply Squeeze will work alongside existing deflationary tools, such as the Community BuyBack.The INJ Supply Squeeze will work alongside existing deflationary tools, such as the Community BuyBack.

Injective Introduces the INJ Supply Squeeze to Bolster Token Scarcity

Layer-1 blockchain Injective has taken another step to make its native cryptocurrency, INJ, more deflationary than it already is.

After a unanimous 99.89% vote in support of a proposal, dubbed IIP-617 (INJ Supply Squeeze), the blockchain development team unveiled the new tool to double down on its deflationary measures.

The INJ Supply Squeeze

Since its mainnet debut in 2021, Injective has explored various ways to make INJ scarce and potentially boost its value. Shortly after launching its mainnet, the L1 network began frequent token burns.

In October 2025, it embraced a Community BuyBack mechanism. Both measures aim to reduce the circulating supply of the cryptocurrency and increase its price in the long term. The L1 blockchain has already permanently removed 6.85 million INJ from existence.

On January 15th, Injective introduced the IIP-617 proposal to its community. This measure permanently increases the rate at which INJ coins are supplied into the market.

The announcement stated that the INJ Supply Squeeze will work alongside existing deflationary measures, such as the Community BuyBacks.

The blockchain’s team believes that these token-reduction mechanisms will bolster INJ’s tokenomics, highlighting that its design is gradually shifting toward “a structurally enhanced deflationary model.”

Impact on INJ’s Price

Injective’s co-founder, Eric Chen, reiterated the impact that these deflationary measures will have on INJ’s overall performance, saying:

Most blockchains and crypto projects adopting a deflationary model do so in an effort to reduce their token’s supply and bolster its value. Still, INJ has yet to experience a notable price uptrend despite its diverse token-reduction mechanisms. At the time of writing, it sold for $4.64.

Notwithstanding, a breakthrough in other forays, such as the staked exchange-traded fund (ETF) business, could bring INJ the much-needed price upturn.

The post Injective Introduces the INJ Supply Squeeze to Bolster Token Scarcity appeared first on CryptoPotato.

Market Opportunity
Injective Logo
Injective Price(INJ)
$4.724
$4.724$4.724
-0.46%
USD
Injective (INJ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Shiba Inu Faces Growing Risks as Leadership Instability Concerns Holders

Shiba Inu Faces Growing Risks as Leadership Instability Concerns Holders

TLDR Shiba Inu faces growing risks due to leadership instability and the absence of its lead developer, Shytoshi Kusama. The lack of identifiable leadership raises trust issues, hindering Shiba Inu’s ability to attract institutional investors. Shibarium’s transaction volume has significantly declined, sparking concerns about its ability to support decentralized finance (DeFi) growth. A recent $3 [...] The post Shiba Inu Faces Growing Risks as Leadership Instability Concerns Holders appeared first on CoinCentral.
Share
Coincentral2025/09/18 06:14
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Iran’s Central Bank Spends $500M on Crypto Amid Rial Crisis

Iran’s Central Bank Spends $500M on Crypto Amid Rial Crisis

Iran's Central Bank has reportedly acquired more than $500 million in cryptocurrency assets over the past year to mitigate the ongoing currency crisis.
Share
coinlineup2026/01/22 08:59